As of 2026-02-18, the EV/EBITDA ratio of Sensyne Health PLC (SENS.L) is 0.13. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SENS.L's latest enterprise value is -4.80 mil GBP. SENS.L's TTM EBITDA according to its financial statements is -35.75 mil GBP. Dividing these 2 quantities gives us the above SENS.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.7x - 9.7x | 8.2x |
| Forward P/E multiples | 6.0x - 10.7x | 7.6x |
| Fair Price | (65.25) - (95.31) | (77.22) |
| Upside | -18741.8% - -27331.6% | -22163.4% |
| Date | EV/EBITDA |